Kyle Faget, Partner, Foley & Lardner LLP, and Devin Cohen, Partner, Proskauer Rose LLP, discuss the current legal and regulatory landscape of clinical trials. They cover issues related to changes to the FDA’s regulatory process, research funding, research misconduct, regulation of wellness products and clinical decision support software, and telehealth and decentralization.